Free Trial

Scienture Q1 2023 Earnings Report

$2.80 +0.07 (+2.56%)
As of 02/21/2025 03:58 PM Eastern

Scienture EPS Results

Actual EPS
-$0.45
Consensus EPS
-$0.30
Beat/Miss
Missed by -$0.15
One Year Ago EPS
N/A

Scienture Revenue Results

Actual Revenue
$2.25 million
Expected Revenue
$2.47 million
Beat/Miss
Missed by -$220.00 thousand
YoY Revenue Growth
N/A

Scienture Announcement Details

Quarter
Q1 2023
Time
N/A

Conference Call Resources

Scienture Earnings Headlines

Elon’s “New Gold”
MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest breakthrough in artificial intelligence… but in human technology. It’s so valuable that some are referring to it as the “new gold”.
See More Scienture Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Scienture? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Scienture and other key companies, straight to your email.

About Scienture

Scienture (NASDAQ:SCNX) engages in the provision of health services and pharmaceutical products. It focuses on addressing underserved patients and indications through novel product concepts and innovation. The company was founded on July 15, 2005 and is headquartered in Lutz, FL.

View Scienture Profile

More Earnings Resources from MarketBeat